Robert Rubin

Robert Joseph Rubin is Chief Medical Officer at Cerium Pharmaceuticals, Inc. since 2022.
He is a Professor of Medicine at Georgetown University since 2012.
He serves as Independent Director at Soligenix, Inc. since 2009, Director at CardioNet LLC since 2007, and Director at Biotel Research LLC.
Formerly, Dr. Rubin was Medical Director at Valuerx, Inc. from 1994 to 1996, Director at Questcor Pharmaceuticals, Inc., Independent Director at BioTelemetry, Inc. from 2014 to 2021, President of The Lewin Group, Inc. from 1987 to 2001, President of Lewin-ICF, Inc. from 1987 to 1992, Principal at ICF, Inc. from 1984 to 1987, Assistant Secretary-Planning & Evaluation at the US Department of Health & Human Services from 1981 to 1984, and President of Lewin-VHI, Inc. from 1992 to 1996.
Education includes undergraduate studies at Williams College and a doctorate from Weill Cornell Medical College.